Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2015-10-01

Original market date: See footnote 1

2003-06-03

Product name:

BALMINIL CODEINE NIGHT TIME + EXPECTORANT

DIN:

02244010 Electronic product monograph is not available

Company:

ROUGIER PHARMA DIVISION OF RATIOPHARM INC
30 Novopharm Court
Toronto
Ontario
Canada M1B 2K9

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Oral

Number of active ingredient(s):

3

Schedule(s):

Narcotic (CDSA I)

 

American Hospital Formulary Service (AHFS): See footnote 3

48:08.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

R05FA02 OPIUM DERIVATIVES AND EXPECTORANTS

Active ingredient group (AIG) number:See footnote5

0311067001

List of active ingredient(s)
Active ingredient(s) Strength
AMMONIUM CHLORIDE 125 MG / 5 ML
CODEINE PHOSPHATE 3.33 MG / 5 ML
DIPHENHYDRAMINE HYDROCHLORIDE 12.5 MG / 5 ML
Version 4.0.2
Date modified: